GeneFerm Biotechnology Co Ltd (1796) — Cash Flow Quality Index
GeneFerm Biotechnology Co Ltd (1796) has a Cash Flow Quality Index of 1.61x as of June 2025. Operating cash flow of NT$1.45 Million exceeds net income of NT$898.00K, indicating high earnings quality where cash backs reported profits. Also explore how large is GeneFerm Biotechnology Co Ltd's balance sheet for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GeneFerm Biotechnology Co Ltd Cash Flow Quality Index (2017–2023)
Historical Cash Flow Quality Index for GeneFerm Biotechnology Co Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GeneFerm Biotechnology Co Ltd (1796) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for GeneFerm Biotechnology Co Ltd (2017–2023)
Year-by-year earnings quality comparison for GeneFerm Biotechnology Co Ltd. For live market cap and the full company financial profile, see GeneFerm Biotechnology Co Ltd stock valuation.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 1.24x | NT$190.31 Million | NT$153.43 Million | ▲ +11.7% |
| 2022 | 1.11x | NT$122.43 Million | NT$110.21 Million | ▼ -30.3% |
| 2021 | 1.59x | NT$112.23 Million | NT$70.40 Million | ▼ -80.9% |
| 2020 | 8.33x | NT$56.42 Million | NT$6.77 Million | ▲ +104.0% |
| 2018 | 4.08x | NT$42.14 Million | NT$10.31 Million | ▲ +88.8% |
| 2017 | 2.16x | NT$61.08 Million | NT$28.23 Million | — |